Literature DB >> 10426862

Reperfusion injury: experimental evidence and clinical implications.

G Ambrosio1, I Tritto.   

Abstract

Postischemic reperfusion may profoundly alter cardiac function. Principal mediators of this phenomenon are oxygen radicals and neutrophils. Upon reflow, oxygen radicals are generated in large amounts, overwhelming cellular defenses and inducing oxidative tissue damage; biochemical markers of oxygen radical formation and attack can be found in postischemic myocardium. Reintroduction of neutrophils in postischemic tissues is accompanied by their activation, with release of lytic enzymes that directly induce tissue damage and proinflammatory mediators that amplify the local inflammatory reaction. Neutrophils may also plug capillaries, mechanically blocking flow. Oxidants can also modulate various events, ultimately leading to tissue injury, such as nitric oxide formation, platelet-activating factor metabolism, tissue factor synthesis, and exposure of adhesion molecules. In the clinical setting, important consequences of postischemic reperfusion are reversible contractile dysfunction ("stunning"), which is mostly caused by oxygen radical attack, and impairment to flow at the microvascular level ("no-reflow") secondary to neutrophil plugging and vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426862     DOI: 10.1016/s0002-8703(99)70323-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  54 in total

1.  Kinetic studies of calcium-induced calcium release in cardiac sarcoplasmic reticulum vesicles.

Authors:  Gina Sánchez; Cecilia Hidalgo; Paulina Donoso
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

Review 2.  Free radicals and redox signalling in cardiovascular disease.

Authors:  A M Shah; K M Channon
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

3.  Gypenosides alleviate myocardial ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function in rat heart.

Authors:  Haijie Yu; Qigang Guan; Liang Guo; Haishan Zhang; Xuefeng Pang; Ying Cheng; Xingang Zhang; Yingxian Sun
Journal:  Cell Stress Chaperones       Date:  2016-01-22       Impact factor: 3.667

Review 4.  Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors.

Authors:  S R Dixon
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 5.  The pathophysiology of myocardial reperfusion: a pathologist's perspective.

Authors:  C Basso; G Thiene
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

Review 6.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

Review 7.  Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Authors:  Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline L Buros; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-09-26       Impact factor: 2.300

8.  Effect of remote ischemic postconditioning during thrombolysis in STEMI.

Authors:  S Ghaffari; L Pourafkari; S Manzouri; N D Nader
Journal:  Herz       Date:  2017-03-17       Impact factor: 1.443

9.  Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.

Authors:  J Grönros; A Kiss; M Palmér; C Jung; D Berkowitz; J Pernow
Journal:  Acta Physiol (Oxf)       Date:  2013-04-15       Impact factor: 6.311

10.  Proinflammatory cytokines in a mouse model of central retinal artery occlusion.

Authors:  Michal Kramer; S Dadon; M Hasanreisoglu; Y Monselise; B R Avraham; A Feldman; I Eldar; D Weinberger; N Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-05-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.